Abstract
The first well-controlled studies of fenofibrate in the United States indicate that the drug is safe and effective for the treatment of type IIa and type lib hyperlipidemia. Fenofibrate produced a marked reduction in triglyceride (TG) levels (p

This publication has 0 references indexed in Scilit: